Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Neuland Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 487.60 18.40  | 3.92% -18.52% 29.37 626.87
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 487.60 18.40 3.92% 476.50 469.20 5,263 468.20 - 490.90
BSE Oct 15, 2019 488.60 20.90 4.47% 465.15 467.70 223 465.15 - 490.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 22,296 P/B: 0.90 NSE Code: NEULANDLAB
52-Week Range: R 425.00 - 827.30 Dividend Yield: 0.25% BSE Code: 524558
TTM EPS: R 16.64 Book Value: R 545.82 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Neuland Laboratories 6.45 -0.78 -5.41 -18.08 -21.10 1.08 15.91
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 26.44 9.35 7.44
Net Profit 36.30 -15.32 -9.28
EPS -5.62 -25.31 -17.46
Book Value 96.37 37.57 28.81
Average
Operating Margin 9.28 12.76 13.75
Net Margin 2.45 4.27 4.30
Return on Networth 3.48 10.28 11.54
Return on Investment 3.99 8.01 11.67
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 4.83 17.57 4.83
Operating Profit -3.28 89.12 -3.28
Net Profit -16.58 1,259.32 -16.58
EPS -16.58 1,259.45 -16.58
TTM
Revenue 4.06 22.60 4.06
Operating Profit 14.66 30.21 14.66
Net Profit 32.22 83.96 32.22
EPS 32.22 29.10 32.22
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Neuland Laboratories 626.87 693.88 21.35 3.06 3.48 0.90 29.37
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 13, 2019 Gannabathula Subayamma  Sell Off Market 5,184 493.10 25.56
Jan 25, 2019 Gannabathula Subayamma  Sell Gift 15,500 497.50 77.11
Jan 09, 2019 Gannabathula Subayamma  Sell Market 2,126 504.60 10.73
May 23, 2018 Malabar India Fund Ltd  Buy QIP Placement 360,000 702.95 2,530.62
May 23, 2018 Steadview Capital Mauritius Ltd  Buy QIP Placement 970,833 702.95 6,824.47
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
ICICI Prudential Mutual Fund 1.914 1.883 1.882 1.754 1.684
SBI Mutual Fund 0.824 2.016 2.015 2.015 2.015
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Neuland Laboratories Ltd.

Address: Sanali Info Park, 'a' Block, Ground Floor,8-2-120/113, Road No.2, Banjara Hills, Hyderabad, Telangana - 500034 | Phone: 040-30211600 | Fax: 040-30211602

Email: [email protected]

Website: www.neulandlabs.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
2.60
Piotroski F-Score
7
Modified C-Score
1
5-Years Price to Earnings
29.37
5-Years Price to Book
0.90
Earnings Yield
EBIT / Enterprise value
5.24%
PEG
Price / Earnings to growth ratio
-59.46
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59